PTN
$0.80
Palatin Technologies
$.01
1.27%
PTN
Earnings Whisper ®
N/A
2nd Quarter December 2019
Consensus:  $0.00
Revenue:  $4.48 Mil
Wednesday
Feb 12
7:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when PTN reports earnings?
Beat
Meet
Miss

Where is PTN's stock price going from here?
Up
Flat
Down
Stock chart of PTN
Analysts
Summary of analysts' recommendations for PTN
Score
Grade
Pivots
Resistance
$0.83
$0.82
$0.81

$0.80

Support
$0.78
$0.77
$0.75
Tweet
Growth
Description
Palatin Technologies, Inc is a development-stage medical technology company involved in developing and commercializing products and technologies for diagnostic imaging, cancer therapy and ethical drug development These developments are based on its proprietary monoclonal antibody radiolabeling and enabling peptide platform technologies.
Peers
BioMarin PharmaceuticalRegeneron PharmaceuticalsInterCeptVertex PharmaceuticalsJohnson & JohnsonZoetisBristol-Myers SquibbEndo International plcMylanUltragenyx Pharmaceutical